Is FUNDACIÓ Institut D'INVESTIGACIÓ BIOMÈDICA DE Bellvitge (IDIBELL)'s patent grant rate increasing or decreasing?

FUNDACIÓ Institut D'INVESTIGACIÓ BIOMÈDICA DE Bellvitge (IDIBELL)'s recent grant velocity is +60% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for FUNDACIÓ Institut D'INVESTIGACIÓ BIOMÈDICA DE Bellvitge (IDIBELL)'s patents?

FUNDACIÓ Institut D'INVESTIGACIÓ BIOMÈDICA DE Bellvitge (IDIBELL)'s patents average 15.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

FUNDACIÓ Institut D'INVESTIGACIÓ BIOMÈDICA DE Bellvitge (IDIBELL)

Q: Where does FUNDACIÓ Institut D'INVESTIGACIÓ BIOMÈDICA DE Bellvitge (IDIBELL) rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), FUNDACIÓ Institut D'INVESTIGACIÓ BIOMÈDICA DE Bellvitge (IDIBELL) ranks #19,794 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

Q: How is the FUNDACIÓ Institut D'INVESTIGACIÓ BIOMÈDICA DE Bellvitge (IDIBELL) patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 14 granted patents across 7 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Fundació ranks #19,794 of 49,997 tracked US assignees by granted-patent volume, with 14 patents across 7 technology areas.

#19,794
of 49,997 US assignees by volume: Top 43%
by Innovation Score (37.7/100): 15.0
avg claims per patent: +60%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R19794 · Foreign Corporation #19,794 · 14 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 14 grants
MID-PACK #19,794/49,997
PHOTO-FINISH Fairly Odd Treasures
CPC-NARROW A61K · 7 areas
INNOV-THIN 37.7/100
CLAIMS-RICH 15.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +60% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Fairly Odd Treasures, LLC. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Fundació’s 37.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.4 pts (25%) Velocity 10.0 pts (26%) Breadth 9.4 pts (25%) Claim depth 9.0 pts (24%)

Qualcomm Incorporated · highest

85
FUNDACIÓ Institut… · this assignee

38
3D Lighting… · lowest

7

What this shows Fundació's Innovation Score is 37.7/100 (top 43% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Fundació?

Each dot is one of Fundació’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Fundació’s own 15.0 claims/patent is ABOVE the 11.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Fundació vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Fundació's grants concentrate

FUNDACIÓ Institut D'INVESTIGACIÓ BIOMÈDICA DE Bellvitge (IDIBELL) is a focused PatentsView assignee: 7 CPC subclasses with 64.3% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2023 (3 grants) versus a trough of 1 in 2016. By volume, Fundació sits between Flexlink AB and Faiveley Transport Amiens.

Fundació's three-year grant acceleration

FUNDACIÓ Institut D'INVESTIGACIÓ BIOMÈDICA DE Bellvitge (IDIBELL) shows 6 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Flexlink AB

14
Foghorn Therapeut…

14
Forever Gifts

14
Fronteo

14
FundaÃO Butantan

14
Future Plants Lic…

14
Fairly Odd Treasu…

14
Faiveley Transpor…

14
FundaciÓ Institut… ◀

14

What this shows FUNDACIÓ holds 14 patents at rank #19,769, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near FUNDACIÓ

By rank, the assignees closest to #19,769 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in FUNDACIÓ's primary technology class.

Fundació's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 43% higher than 57% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

FUNDACIÓ Institut D'INVESTIGACIÓ BIOMÈDICA DE Bellvitge (IDIBELL) patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	7.1%
2017	1	7.1%
2018	1	7.1%
2019	2	14.3%
2020	1	7.1%
2021	1	7.1%
2023	3	21.4%
2024	3	21.4%
2025partial year	1	7.1%

Which technologies does FUNDACIÓ Institut D'INVESTIGACIÓ BIOMÈDICA DE Bellvitge (IDIBELL) patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 9

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 8

C07K - Peptides 7

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 6

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 3

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

C07J - Steroids 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

FUNDACIÓ Institut D'INVESTIGACIÓ BIOMÈDICA DE Bellvitge (IDIBELL)'s patent record in context - here's where to go next.

FUNDACIÓ Institut D'INVESTIGACIÓ BIOMÈDICA DE Bellvitge (IDIBELL)'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 64.3% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #19,794 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare FUNDACIÓ Institut D'INVESTIGACIÓ BIOMÈDICA DE Bellvitge (IDIBELL) against Flexlink AB, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 37.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.